Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. Gopalsamy A, Aulabaugh AE, Barakat A, Beaumont KC, Cabral S, Canterbury DP, et al. PF-07059013: a noncovalent modulator of hemoglobin for treatment of sickle cell disease. J Med Chem. 2021;64(1):326–42.
2. Sundd P, Gladwin MT, Novelli EM. Pathophysiology of sickle cell disease. Annu Rev Pathol. 2019;14:263–92.
3. Ahmed MH, Ghatge MS, Safo MK. Hemoglobin: structure, function and allostery. Subcell Biochem. 2020;94:345–82.
4. Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet. 2010;376(9757):2018–31.
5. Odievre MH, Verger E, Silva-Pinto AC, Elion J. Pathophysiological insights in sickle cell disease. Indian J Med Res. 2011;134(4):532–7.